Dana-Farber Cancer Center

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber Cancer Center
Dec 29, 2024, 11:15 | Blog
Narjust Florez: Day 6 of attending during the holidays
Narjust Florez, Associate Director of the Cancer Care Equity Program at the Dana-Farber Brigham Cancer…
Dec 12, 2024, 16:51 | Insight
Insights from SABCS24 by Matteo Lambertini
The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 28, 2024, 00:11 | Blog
ALCSI - Distinguished Lecture Series Event with Dr. Narjust Florez
ALCSI shared on X: "We are so excited for our Distinguished Lecture Series Event at 7…
Oct 12, 2024, 12:43 | Blog
The 7th Annual B-PREP Patient Forum - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join us on Sat, Oct 19th, 9…
Oct 10, 2024, 09:24 | Blog
Alan Rubin: Looking forward to my 4th Jimmy Fund Walk with
Alan Rubin shared a post on X: "Special day, for so many reasons. Already looking forward…
Oct 9, 2024, 14:10 | Stories
David Thau's Journey with Colon Cancer: From Patient to Advocate
What motivated David Thau to become one of the top fundraisers? David Thau is recognized…
Oct 6, 2024, 16:57 | Blog
Sarah Sammons: Sound advice on how to help a friend with cancer
Sarah Sammons shared a post on X: "I am very lucky to know Renée and she…
Oct 2, 2024, 14:56 | Insight
The most recent Breast Cancer Research Digest by Dana-Farber
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…
Sep 24, 2024, 12:29 | Blog
Caterina Sposetti: Excess weight and risk of 2nd primary tumors in early-stage cancer survivors
Caterina Sposetti, Medical Oncology Fellow, Dana-Farber Cancer Center, shared a post on X: "New interesting…
Sep 14, 2024, 15:42 | Blog
Lauren Merz: A brilliant piece on a nuanced subject that impacts millions of people
Lauren Merz, Hemat/onc fellow at Dana-Farber Institute, shared a post on X: "Cheers to STAT News…
Sep 14, 2024, 15:33 | Insight
Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma
Toni Choueiri shared a post on X about a recent paper by Brian Shuch et…
Sep 9, 2024, 11:13 | Insight
Benjamin Ebert is the New President and CEO of Dana-Farber Cancer Center
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Sep 8, 2024, 02:35 | Career
The New President and CEO of Dana-Farber Cancer Center - Benjamin Ebert
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center…
Aug 5, 2024, 14:36 | Blog
George Demetri: What an amazing day at PMC2024
George Demetri, Director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, shared on X: "PMC2024…
Jul 25, 2024, 11:12 | Societies
8 Posts From ANZUP24 That You Should Not Miss!
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) organized their ANZUP24 Annual…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Jul 12, 2024, 20:47 | Societies
Stuart Schnitt on the future of breast pathology with the potential benefits of AI
Sara Tolaney shared on X: "Dr Stuart Schnitt does an outstanding job highlighting the future…
Jun 20, 2024, 07:36 | Blog
LGBTQ+ patients report on their cancer care journey
Estela Rodriguez shared a post on X: "Disparities uncovered: LGBTQ+ patients report on their cancer care…
Apr 28, 2024, 21:10 | Drugs
Doug Rubinson: The best drug in GI cancers is 5-FU
Doug Rubinson, GI Medical Oncologist At Dana-Farber Cancer Centre, shared on X/Twitter: "In oncology, we…
Apr 12, 2024, 16:30 | Insight
Douglas Flora: NEJM AI and the team at Dana-Farber Cancer Center just published a great case study in which they revealed some insights following the (careful) deployment of generative AI
Apr 8, 2024, 14:26 | Drugs
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Dana-Farber’s Breast Oncology Center posted on X: "We are leading a randomized Phase 2 trial for…
Mar 27, 2024, 14:24 | Blog
Elad Sharon: A great honor to speak at The Tisch Cancer Institute this week at Hematology Oncology Grand Rounds
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared a post by The Tisch Cancer Institute,…
Mar 16, 2024, 20:43 | Insight
Humaid Al-Shamsi: Pleased to share with you our latest 2 publications published on the same day about lung cancer
Humaid Al-Shamsi, Director of Burjeel Cancer Institute Comprehensive Cancer Center and Burjeel Holdings Oncology UAE,…
Nov 4, 2023, 00:39 | Opinion
Narjust Florez: Discharge is the time when patients are most vulnerable
Narjust Florez shared in Twitter: "Discharge is the time when patients are most vulnerable. A…
All: 25 Posts: 1 - 100
Special Coverage